Nicholas C. Cullen

Malmoe, M 20213, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217.

Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217.

Journal: Alzheimer's research & therapy

Published: September 13, 2024

Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.

Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.

Journal: Research square

Published: November 21, 2023

Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.

Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: November 07, 2023

Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.

Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.

Journal: Alzheimer's research & therapy

Published: November 06, 2023

Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementia.

Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementia.

Journal: Brain communications

Published: May 22, 2023

Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementia.

Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementia.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2023

Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial.

Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial.

Journal: EBioMedicine

Published: March 31, 2023

A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings.

A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings.

Journal: Nature communications

Published: January 26, 2023

A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases.

A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases.

Journal: Nature aging

Published: January 11, 2023

Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes.

Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 03, 2022

Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.

Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 26, 2022

Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients.

Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: May 16, 2022

Showing 1-12 of 41

Last Updated: 09/26/2026